Infection of cerebrospinal fluid shunt systems;Infecciones relacionadas con los sistemas de drenaje de líquido cefalorraquídeo

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 4, 2008, Pages 240-251

  Jiménez Mejías, Manuel E ^a   García Cabrera, Emilio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Cerebrospinal fluid shunt; External cerebrospinal fluid drains; Infection

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIUM CULTURE; BIOFILM; CELL COUNT; CEREBROSPINAL FLUID; CLINICAL FEATURE; GRAM NEGATIVE BACTERIUM; GRAM STAINING; HUMAN; MENINGITIS; PROPIONIBACTERIUM; REVIEW; SHUNT INFECTION; WOUND INFECTION;

EID: 42149094410     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/s0213-005x(08)72696-x     Document Type: Review

References (48)

1. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422-9.
2. National Nosocomial Infections Surveillance (NNSI) System Report, data summary from January 1992 to June 2002. Am J Infect Control. 2002;30:458-75.
3. Weisfelt M, Van der Beek D, Spanjaard L, de Gans J. Nosocomial bacterial meningitis in adults, a prospective series of 50 cases. J Hosp Infect. 2007;66:71-8.
4. Wang KW, Chang WN, Huang CR, Tsai NW, Tsui HW, Wang HC, et al. Post-surgical nosocomial bacterial meningitis in adults: microbiology, clinical features, and outcomes. J Clin Neurosci. 2005;12:647-50.
5. Schade RP, Schinkel J, Roelandse FWC, Geskus RB, Visser LG, Van Dijk MC, et al. Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis. J Neurosurg. 2006;104:101-8.
6. Pfisterer W, Mühlbauer M, Czech T, Reinprecht A. Early diagnosis of external ventricular drainage infection: results of a prospective study. J Neurol Neurosurg Psychiatry. 2003;74:929-32.
7. Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003;98:725-30.
8. Schade RP, Schinkel J, Visser LG, Van Dijk JMC, Voormolen JHC, Kuijper EJ. Bacterial meningitis caused by the use of ventricular or lumbar cerebrospinal fluid catheters. J Neurosurg. 2005;102:229-34.
9. Lozier AP, Sciacca RRE, Romagnoli MF, Connolly ES Jr. Ventriculostomy-related infections: A critical review of the literature. Neurosurgery. 2002;51:170-82.
10. Thompson DNP, Hartley JC, Path MR, Hayward RD. Shunt infection: is there a near-miss scenario? J Neurosurg (1 Suppl Pediatrics). 2007;106:15-9.
11. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95-108.
12. Braxton EE, Ehrlich GD, Hall-Stoodley L, Stoodley P, Veeh R, Fux C, et al. Role of biofilm in neurosurgical device-related infections. Neurosurg Rev. 2005;28:249-55.
13. Vila J, Soriano A, Mensa J. Bases moleculares de la adherencia microbiana sobre los materiales protésicos. Papel de las biocapas en las infecciones asociadas a materiales protésicos. Enferm Infecc Microbiol Clin. 2008;26:48-55.
14. Zheng Z, Stewart PS. Penetration of Rifampin through Staphylococcus epidermidis Biofilms. Antimicrob Agents Chemother. 2002;46:900-3.
15. Anderl JN, Zahller J, Roe F, Stewart PS. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 2003;47:1251-6.
16. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracelullar DNA required for bacterial biofilm formation. Science. 2002;295:1487.
17. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis. 2003;36:858-62.
18. Wang KW, Chang WN, Shih TY, Huang CR, Tsai NW, Chang CS, et al. Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes. Jpn J Infect Dis. 2004;57:44-8.
19. McClelland III S, Hall WA. Postoperative central nervous system infection: incidence and associated factors in 2,111 neurosurgical procedures. Clin Infect Dis. 2007;45:55-9.
20. McClinton D, Carraccio C, Englander R. Predictors of ventriculoperitoneal shunt pathology. Pediatr Infect Dis J. 2001;20:593-7.
21. Jiménez-Mejías ME, Márquez-Rivas J, Terrones R, Palomino-Nicás J, Rodríguez-Burgos F, Pachón J. Colonization/infection of ventriculoperitoneal shunt (VPS) by Propionibacterium acnes: a frequent cause of VPS failures. 12th European Congress of Clinical Microbiology and Infectious Diseases. Milan, 24-27 April 2002. Clin Microbiol Infect. 2002;8 Suppl 1:359-60.
22. Zunt JR. Iatrogenic Infections of the Central Nervous System. En: Scheld WM, Whitley RJ, Marra CM, editors. Infections of the central nervous system. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 569-81.
23. Bayston R, Leung TS, Wilkins BM, Hodges B. Bacteriological examination of removed cerebrospinal fluid shunt. J Clin Pathol. 1983;36:987-90.
24. Filka J, Huttova M, Tuharsky J, Sagat T, Kralinsky K, Krcmery V Jr. Nosocomial meningitis in children after ventriculoperitoneal shunt insertion. Acta Paediatr. 1999;88:576-8.
25. Lam S, Gomolin IH. Cefepime neurotoxicity: Case report, pharmacokinetic considerations, and literature review. Pharmacotherapy. 2006;26:1169-74.
26. Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother. 2007;41:296-308.
27. Boak LM, Li J, Spelman D, Du Cros P, Nation RL, Rayner CR. Successful treatment and cerobrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis. Ann Pharmacother. 2006;40:1451-5.
28. Bayston R, Nuradeen B, Ashraf W, Freeman BJC. Antibiotics for the eradication of propionibacterium acnes biofilms in surgical infection. J Antimicrob Chemother. 2007;60:1298-301.
29. Karakitsos D, Paramythiotou E, Samonis G, Karabinis A. Is Intraventricular colistin an effective and safe treatment for post-surgical ventriculitis in the intensive care unit? Acta Anaesthesiol Scand. 2006;50:1309-10.
30. Bayston R. Epidemiology, diagnosis, treatment, and prevention of cerebrospinal fluid shunt infections. Neurosurg Clin North Am. 2001;36:703-8.
31. Williamson JC, Glazier SS, Peacock JE Jr. Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/ dalfopristin. Clin Neurol Neurosurg. 2002;104:54-6.
32. Schreffler RT, Schreffler AJ, Wittler RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J. 2002;21:632-6.
33. Kallweit U, Harzheim M, Marklein G, Pöhlau D. Successful treatment of meticilin-resistant Staphylococcus aureus meningitis using linezolid without removal of intrathecal infusion pump. Case report. J Neurosurg. 2007;107:651-3.
34. Castro P, Soriano A, Escrich C, Villalba G, Sarasa M, Mensa J. Linezolid treatment of ventriculoperitoneal shunt infection without implant removal. Eur J Clin Microbiol Infect Dis. 2005;24:603-6.
35. Gardner P, Leipzig T, Phillips P. Infections of central nervous system shunts. Med Clin North Am. 1985;69:297-314.
36. Vajramani GV, Jones G, Bayston R, Gray WP. Persistent and intractable ventriculitis due to retained ventricular catheters. 2005;19:496-501.
37. Holloway KL, Barnes T, Choi S, Bullock R, Marshall LF, Eisenberg HM, et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg. 1996;85:419-24.
38. Langley JM, LeBlanc JC, Drake J, Milner R. Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. Clin Infect Dis. 1993;17:98-103.
39. Lyke KE, Obasanjo OO, Willians MA, O'Brien M, Chotani R, Perl TM. Ventriculitis complicating the use of intraventricular catheters in neurosurgical patients. Clin Infct Dis 2001;2028-33.
40. Ragel BT, Browd SR, Schmidt RH. Surgical shunt infection: significant reduction when using intraventricular and systemic antibiotic agents. J Neurosurg. 2006;105:242-7.
41. Haines SJ, Walters BC. Antibiotics prophylaxis for cerebrospinal fluid shunt. Neurosurgery. 1994;34:87:92.
42. Bayston R, Ashraf W, Bhundia C. Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother. 2004;53:778-82.
43. Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, et al. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg. 2006;103:131-6.
44. Pattavilakom A, Xenos C, Bradfield O, Danks RA. Reduction in shunt infection using antibiotic ionpregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci. 2007;14:526-31.
45. Alleyne CH, Hassan M, Zabramski JM. The efficacy and copst of prophylactic and periprocedural antibiotics in patients with external ventricular drains. Neurosurgery. 2000;47:1124-9.
46. Mayhall CG, Archer NH, Lamb VA, Spadora AC, Baggett JW, Ward JD, et al. Ventriculostomy-related infections: a prospective epidemiology study. N Engl J Med. 1984;310:553-9.
47. Wong GKC, Poon WS, Wai S, Yu LM, Lyon D, Lam JMK. Failure of regular external ventricular drain exchange to reduce cerebrospinal fluid infection: result of a randomized controlled trial. J Neurol Neurosurg Psychiatry. 2002;73:759-61.
48. Elvy J, Porter D, Brown E. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin. J Antimicrob Chemother. 2008;61:461-2.